Annual Drug Patent Expirations for XARACOLL
Xaracoll is a drug marketed by Innocoll Pharms and is included in one NDA. It is available from one supplier. There is one patent protecting this drug.
This drug has seventeen patent family members in fifteen countries.
The generic ingredient in XARACOLL is bupivacaine hydrochloride. One supplier is listed for this compound. Additional details are available on the bupivacaine hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
